Novus Therapeutics Inc. (NVUS) Gained 11.09% or 0.57 To Price $5.71 On Monday


Novus Therapeutics Inc. (NVUS) gained 11.09% or 0.57 to $5.71. It is around 191134 shares traded, which is 306.2% compare to the average total volume 62421. The market cap of NVUS is $53.71 million. The year to date change is 29.15%. The 52 week price range is from $3.12 to $6.6. Price of NVUS have changed 18.98% during last week. It have changed 3.63% over last month, 62.15% over last 3 months, 34.91% over last 6 months and -11.23% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVUS is 4.80. It is -15.94% below current price. The 200-day Moving Averages for NVUS is 4.28. It is -25.04% below current price. The 52-week High is 6.6. It is 15.59% from the current price. The 52-week Low is 3.12. It is -45.36% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVUS is 0.82 on 2018-04-30. Short % to float is 0.28%. There are some statistics of NVUS. It is has market cap $53.71 million. The share outstanding is 9.41 million. The average volume is 62421. The percent of top 15 Institution holding is 72.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVUS is -131.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVUS is -96.85%.


Tags:

Share this post